Adherence to infliximab treatment in a pediatric inflammatory bowel disease cohort

David S. Vitale; Rachel N. Greenley; Diana G. Lerner; Alisha M. Mavis; Steven L. Werlin

doi:10.1097/MPG.0000000000000817

Adherence to infliximab treatment in a pediatric inflammatory bowel disease cohort

David S. Vitale, Rachel N. Greenley, Diana G. Lerner, Alisha M. Mavis, Steven L. Werlin^*

^*Corresponding author for this work

Pediatrics

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

The aims of the study were to describe infliximab adherence in a pediatric inflammatory bowel disease cohort, to identify demographic and disease factors associated with adherence, and to examine differences in acute care use among adherent and nonadherent patients. Charts of patients who received infliximab at the Children's Hospital of Wisconsin (CHW) between October 2010 and October 2012 were retrospectively reviewed. A total of 151 patients met the inclusion criteria; 91.4% of the patients were adherent. Nonadherent patients had more emergency room visits and hospitalizations than adherent patients. The study is the first to show high adherence rates to infliximab in a pediatric cohort.

Original language	English (US)
Pages (from-to)	408-410
Number of pages	3
Journal	Journal of pediatric gastroenterology and nutrition
Volume	61
Issue number	4
DOIs	https://doi.org/10.1097/MPG.0000000000000817
State	Published - Oct 1 2015

Keywords

Adherence
Inflammatory bowel disease
Infliximab
Pediatric

ASJC Scopus subject areas

Gastroenterology
Pediatrics, Perinatology, and Child Health

Access to Document

10.1097/MPG.0000000000000817

Cite this

@article{5bfe711826464b41b8af2e286421c1f5,

title = "Adherence to infliximab treatment in a pediatric inflammatory bowel disease cohort",

abstract = "The aims of the study were to describe infliximab adherence in a pediatric inflammatory bowel disease cohort, to identify demographic and disease factors associated with adherence, and to examine differences in acute care use among adherent and nonadherent patients. Charts of patients who received infliximab at the Children's Hospital of Wisconsin (CHW) between October 2010 and October 2012 were retrospectively reviewed. A total of 151 patients met the inclusion criteria; 91.4% of the patients were adherent. Nonadherent patients had more emergency room visits and hospitalizations than adherent patients. The study is the first to show high adherence rates to infliximab in a pediatric cohort.",

keywords = "Adherence, Inflammatory bowel disease, Infliximab, Pediatric",

author = "Vitale, {David S.} and Greenley, {Rachel N.} and Lerner, {Diana G.} and Mavis, {Alisha M.} and Werlin, {Steven L.}",

note = "Publisher Copyright: Copyright {\textcopyright} 2015 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.",

year = "2015",

month = oct,

day = "1",

doi = "10.1097/MPG.0000000000000817",

language = "English (US)",

volume = "61",

pages = "408--410",

journal = "Journal of pediatric gastroenterology and nutrition",

issn = "0277-2116",

publisher = "Lippincott Williams and Wilkins",

number = "4",

}

TY - JOUR

T1 - Adherence to infliximab treatment in a pediatric inflammatory bowel disease cohort

AU - Vitale, David S.

AU - Greenley, Rachel N.

AU - Lerner, Diana G.

AU - Mavis, Alisha M.

AU - Werlin, Steven L.

N1 - Publisher Copyright: Copyright © 2015 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

PY - 2015/10/1

Y1 - 2015/10/1

N2 - The aims of the study were to describe infliximab adherence in a pediatric inflammatory bowel disease cohort, to identify demographic and disease factors associated with adherence, and to examine differences in acute care use among adherent and nonadherent patients. Charts of patients who received infliximab at the Children's Hospital of Wisconsin (CHW) between October 2010 and October 2012 were retrospectively reviewed. A total of 151 patients met the inclusion criteria; 91.4% of the patients were adherent. Nonadherent patients had more emergency room visits and hospitalizations than adherent patients. The study is the first to show high adherence rates to infliximab in a pediatric cohort.

AB - The aims of the study were to describe infliximab adherence in a pediatric inflammatory bowel disease cohort, to identify demographic and disease factors associated with adherence, and to examine differences in acute care use among adherent and nonadherent patients. Charts of patients who received infliximab at the Children's Hospital of Wisconsin (CHW) between October 2010 and October 2012 were retrospectively reviewed. A total of 151 patients met the inclusion criteria; 91.4% of the patients were adherent. Nonadherent patients had more emergency room visits and hospitalizations than adherent patients. The study is the first to show high adherence rates to infliximab in a pediatric cohort.

KW - Adherence

KW - Inflammatory bowel disease

KW - Infliximab

KW - Pediatric

UR - http://www.scopus.com/inward/record.url?scp=84942509029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942509029&partnerID=8YFLogxK

U2 - 10.1097/MPG.0000000000000817

DO - 10.1097/MPG.0000000000000817

M3 - Article

C2 - 25885878

AN - SCOPUS:84942509029

SN - 0277-2116

VL - 61

SP - 408

EP - 410

JO - Journal of pediatric gastroenterology and nutrition

JF - Journal of pediatric gastroenterology and nutrition

IS - 4

ER -

Adherence to infliximab treatment in a pediatric inflammatory bowel disease cohort

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this